Mass spectrometry‐based clinical proteomics: Head‐and‐neck cancer biomarkers and drug‐targets discovery-Reference-Cited by-同舟云学术

Mass spectrometry‐based clinical proteomics: Head‐and‐neck cancer biomarkers and drug‐targets discovery

Author:

Matta Ajay¹,Ralhan Ranju¹²³⁴⁵,DeSouza Leroi V.¹,Siu K.W. Michael¹

Affiliation:

1. Department of Chemistry, Centre for Research in Mass Spectrometry, York University, 4700 Keele Street, Toronto, Ontario, Canada M3J 1P3

2. Joseph and Mildred Sonshine Family Centre for Head and Neck Disease, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1X5

3. Department of Otolaryngology‐Head and Neck Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 2N2

4. Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

5. Department of Otolaryngology‐Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada M5G 2N2

Funder

Canadian Institutes of Health Research

Ontario Institute for Cancer Research

Publisher

Wiley

Subject

Spectroscopy,General Biochemistry, Genetics and Molecular Biology,Condensed Matter Physics,Analytical Chemistry

Link

Reference126 articles.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Biomarkers in ovarian cancer and saliva: An update;Journal of Reproductive Healthcare and Medicine;2021-01-16